Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH  Basil C. Tarlatzis,

Similar presentations


Presentation on theme: "Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH  Basil C. Tarlatzis,"— Presentation transcript:

1 Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH  Basil C. Tarlatzis, Georg Griesinger, Arthur Leader, Luk Rombauts, Pieta C. IJzerman-Boon, Bernadette M.J.L. Mannaerts  Reproductive BioMedicine Online  Volume 24, Issue 4, Pages (April 2012) DOI: /j.rbmo Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions

2 Figure 1 Ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or recombinant FSH (rFSH). Data from (A) Engage and Ensure (pooled) and (B) Trust. Reproductive BioMedicine Online  , DOI: ( /j.rbmo ) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions

3 Figure 2 Receiver operating characteristic curve for logistic regression model. The area under the curve is 0.753, showing the sensitivity of the final logistic regression model. Reproductive BioMedicine Online  , DOI: ( /j.rbmo ) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions


Download ppt "Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH  Basil C. Tarlatzis,"

Similar presentations


Ads by Google